Article
Identifying SETBP1 haploinsufficiency molecular pathways to improve patient diagnosis using induced pluripotent stem cells and neural disease modelling.
Molecular autism - 30 Sept 2024
Shaw Nicole C, Chen Kevin, Farley Kathryn O, Hedges Mitchell, Forbes Catherine, Baynam Gareth, Lassmann Timo, Fear Vanessa S
Abstract excerpt
BACKGROUND: SETBP1 Haploinsufficiency Disorder (SETBP1-HD) is characterised by mild to moderate intellectual disability, speech and language impairment, mild motor developmental delay, behavioural issues, hypotonia, mild facial dysmorphisms, and vision impairment. Despite a clear link between SETBP1 mutations and neurodevelopmental disorders the precise role of SETBP1 in neural development remains elusive. We...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
